MarketCap
Facebook
X
TelegramAnnual report 2025
added 12-05-2025
The Cooper Companies Interest Expense 2011-2025 | COO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense The Cooper Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.4 M | -9.1 M | -14.9 M | 25 M | 23.1 M | 36.8 M | 68 M | 82.7 M | 33.4 M | 26.2 M | 18.1 M | 7.96 M | 9.17 M | 11.8 M | 17.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.7 M | -16.4 M | 21.3 M |
Quarterly Interest Expense The Cooper Companies
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.6 M | -16.1 M | -2.7 M | - | -300 K | -2.8 M | -3.2 M | - | -6 M | 26.1 M | 26.1 M | 34.5 M | 17.1 M | 10.8 M | 6.4 M | 18.1 M | 5.6 M | 6.1 M | 11.6 M | 30.1 M | 5.7 M | 12.8 M | 18.2 M | 53.3 M | 16.7 M | 18.5 M | 18.4 M | 59.9 M | 22.8 M | 18.7 M | 7.3 M | 23.3 M | 8.3 M | 7.7 M | 5.3 M | 20.9 M | 8 M | 7.6 M | 3.94 M | 13.3 M | 4.69 M | 4.69 M | 1.66 M | 4.71 M | 1.5 M | 1.56 M | 2.57 M | 7.27 M | 2.26 M | 2.44 M | 3.66 M | 9.05 M | 2.32 M | 3.07 M | 6.95 M | 14.4 M | 3.22 M | 4.27 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 59.9 M | -16.1 M | 10.6 M |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
497 K | $ 24.56 | 0.7 % | $ 1.13 B |  USA |
 |
Baxter International
BAX
|
408 M | $ 19.52 | 1.93 % | $ 9.96 B | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 200.48 | -0.23 % | $ 57.7 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Harvard Bioscience
HBIO
|
-227 K | $ 0.71 | -4.45 % | $ 30.1 M | USA |
 |
ICU Medical
ICUI
|
107 M | $ 148.28 | -0.1 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
1.25 M | $ 170.21 | 0.82 % | $ 5.31 B | USA |
 |
Alcon
ALC
|
192 M | $ 79.15 | 0.43 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-326 K | $ 41.07 | -3.09 % | $ 1.93 B | USA |
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
6.3 M | $ 4.85 | 2.11 % | $ 26.7 K | USA |
 |
Repro Med Systems
KRMD
|
561 K | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 13.42 | 2.13 % | $ 548 M | USA |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 83.04 | -1.14 % | $ 1.86 B | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 111.73 | 2.6 % | $ 5.41 B | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 137.35 | -0.72 % | $ 7.32 B | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 80.24 | -3.89 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 9.22 | -0.27 % | $ 190 M | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 86.49 | -0.24 % | $ 5.04 B | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
OraSure Technologies
OSUR
|
-380 K | $ 2.49 | - | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 2.23 | -7.65 % | $ 22.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.36 | -7.4 % | $ 28.7 M | USA |
 |
Nephros
NEPH
|
2 K | $ 4.98 | -0.8 % | $ 51.7 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 251.67 | -0.27 % | $ 36.8 B | USA |
 |
Envista Holdings Corporation
NVST
|
-100 K | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 44.0 | 1.43 % | $ 145 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 23.49 | -2.65 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 253.98 | 0.82 % | $ 25 B | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.35 | -1.05 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
983 K | $ 14.04 | -1.4 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 160.09 | 1.72 % | $ 8.92 M | USA |
 |
Utah Medical Products
UTMD
|
256 K | $ 57.54 | -0.96 % | $ 209 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 11.43 | -1.21 % | $ 2.32 B | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.84 | 1.99 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 126.88 | 0.17 % | $ 5.94 B | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 271.82 | 1.6 % | $ 19.8 B | USA |